Vaccine Market - By Technology & Types, Trend Analysis By Various Classes - Live / Attenuated, Subunit, Toxoid, Conjugate, DNA, Recombinant Vector, Synthetic, Dentritic Vaccines And By Indications - Infectious Diseases, Cancer, Allergy, Diabetes, Cardiova - MarketsandMarkets

Vaccine Market - By Technology & Types, Trend Analysis By Various Classes - Live / Attenuated, Subunit, Toxoid, Conjugate, DNA, Recombinant Vector, Synthetic, Dentritic Vaccines And By Indications - Infectious Diseases, Cancer, Allergy, Diabetes, Cardiova

Vaccine Market - By Technology & Types, Trend Analysis By Various Classes - Live / Attenuated, Subunit, Toxoid, Conjugate, DNA, Recombinant Vector, Synthetic, Dentritic Vaccines And By Indications - Infectious Diseases, Cancer, Allergy, Diabetes, Cardiova - MarketsandMarkets
Vaccine Market - By Technology & Types, Trend Analysis By Various Classes - Live / Attenuated, Subunit, Toxoid, Conjugate, DNA, Recombinant Vector, Synthetic, Dentritic Vaccines And By Indications - Infectious Diseases, Cancer, Allergy, Diabetes, Cardiova
Published Aug 12, 2012
195 pages — Published Aug 12, 2012
Price US$ 4,650.00  |  Buy this Report Now

About This Report

  
Abstract:



The vaccine technology market is an established segment and is widely accepted as an indispensable division of the healthcare industry. It is poised to grow rapidly by addressing the following: emerging infectious agents, various types of cancer, allergies, cardiovascular diseases, diabetes, smoke cessation, and neurodegenerative disorders. The global vaccine market is estimated at $32.05 billion in 2013 and is expected to reach $84.44 billion by 2022.

In general, the vaccine technology market is largely perceived negatively as a low-profit venture owing to the domination of top five companies, namely, Sanofi (France), Glaxo Smithkline (U.K.), Merck (U.S.), Pfizer (U.S.), and Novartis (Switzerland). Furthermore, a strong patent portfolio and the need for large investments towards vaccine development have limited the scope of entry for new companies.

The vaccine technology market is analyzed both in terms of qualitative (technological) and quantitative (revenue) perspectives. The technological analysis includes a discussion on different classes of vaccines, vaccine adjuvants, and commercially available products. The market revenue analysis includes market segmentation and the expected market position by 2022, with the projected growth rate.

The vaccine market is classified by technology class, types, end users, disease indication, and geography. The details on the emerging approaches to vaccine development such as reverse vaccinology, personalized vaccinomics, and systems vaccinomics are discussed. Furthermore, key research centers, with their critical areas of research in the vaccine space, have been provided.

An overview of regulations across various geographical regions has been covered. The complete value chain of the vaccine market is schematically represented and the significance of each stakeholder has been briefed.

Apart from the technological and market analysis, the investor climate has been assessed by tracking the complete investor network and collecting data on funds/grants and investments made towards vaccine development. Insights on current and future technological investment trends have also been discussed.

A large number of potential therapeutic and preventive vaccine candidates addressing various diseases which are in the pipeline are listed with their current status in clinical trials.
The adoption and developmental potential of the vaccine technology market has been discussed on a geographic basis, namely, North America, Europe, Asia, and the Rest of the World, by taking select countries that are poised to have a greater market value during the forecast period.

In brief, this research report provides:

A detailed description of the global technology developments and evolving trends in the vaccine field with key prominence on research innovations, collaborative efforts, and investments for vaccines.
A close view on the therapeutic vaccines for various diseases by providing details and status of current vaccines in the pipeline.
An impact analysis of the major drivers and restraints influencing the adoption and growth of the vaccine market during the period of 2013 to 2022.
Porters five forces analysis and GAP analysis.
The global market forecast for 2013 - 2022, including demand side analysis and strategic recommendations for technology/product developers.
Competitive landscape tracking industry activities such as mergers, acquisitions, partnerships, collaborations, and strategic agreements within the vaccine market. Intellectual property strength analysis based on the number of patents filed by the top five players within the vaccine market that gives an insight into prominent activities and global leaders of the industry.

  
Source:
Document ID
MD 2020
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

Title
Table Of Contents

1 Introduction (Page No. - 19)
1.1 Key Take-Aways
1.2 Report Scope
1.3 Report Segmentation
1.4 Research Methodology
1.5 Key Data Points From Secondary And Primary Sources
1.6 Logical Assumptions In This Study Based On Reliable Sources

2 Executive Summary (Page No. - 26)

3 Technology Snapshot (Page No. - 31)
3.1 Technology - Introduction
3.2 Technology - Evolution
3.3 Technology Segmentation
3.4 Technology Trends - By Class
3.4.1 Adjuvants
3.5 Key Vaccine Products In The Market
3.6 Technology Roadmap

4 Vaccine Research Portfolio (Page No. - 42)
4.1 Global Research Portfolio - Research And Development Network
4.2 Emerging Approaches To Vaccine Developments
4.3 Key Research Centres

5 Value Chain Analysis (Page No. - 47)
5.1 Overview
5.2 Cold Chain Management
5.3 Key Stakeholders
5.4 Gap Analysis
5.5 Porters Five Force Analysis

6 Market Landscape (Page No. - 57)
6.1 Global Vaccine Technologies Market, Global Forecasts (2013 - 2022)
6.1.1 Global Vaccine Technologies Market, By Geography, 2012 - 2022
6.1.2 Vaccine Technologies Market Segmentation
6.1.3 Market Dynamics
6.1.3.1 Drivers
6.1.3.2 Restraints
6.1.3.3 Opportunities, Threats And Challenges
6.2 Global Vaccine Technologies Market, By End-User, 2012-2022
6.2.1 Global Vaccine Technologies Market Share, By End-User, 2012 - 2022
6.2.2 Paedriatic Vaccine Market, By Geography
6.2.3 Global Paedriatic Vaccine Market Share, By Geography
6.2.4 Global Adult Vaccine Market, By Geography
6.2.5 Global Adult Vaccine Market Share, By Geography
6.3 Global Vaccine Technologies Market, By Type, 2012-2022
6.3.1 Global Vaccine Technologies Market Share, By Type, 2012-2022
6.3.2 Global Preventive Vaccine Market, By Geography, 2012 - 2022
6.3.3 Global Preventive Vaccine Market Share, By Geography, 2012-2022
6.3.4 Global Therapeutic Vaccine Market, By Geography, 2012 - 2022
6.3.5 Global Therapeutic Vaccine Market Share, By Geography, 2012 - 2022
6.4 Global Vaccine Technologies Market, By Class, 2012 - 2022
6.4.1 Global Vaccine Technologies Market Share, By Class, 2012-2022
6.4.2 Live/Attenuated Vaccine Market, By Geography
6.4.2.1 Live/ Attenuated Vaccine Market Share, By Geography
6.4.3 Toxoid Vaccine Market, By Geography
6.4.3.1 Toxoid Vaccine Market Share, By Geography
6.4.4 Conjugate Vaccine Market, By Geography
6.4.4.1 Conjugate Vaccine Market Share, By Geography
6.4.5 Sub-Unit Vaccine Market, By Geography
6.4.6 Recombinant Vector Vaccine Market, By Geography, 2012 - 2022
6.4.7 Dna Vaccine Market, By Geography, 2012 - 2022
6.4.8 Synthetic Vaccine Market, By Geography, 2012 - 2022
6.4.8.1 Synthetic Vaccine Market Share, By Geography, 2012 - 2022
6.4.9 Dentritic Vaccine Market, By Geography, 2012 - 2022
6.5 Vaccine Technology Market, By Disease Indication (2012 - 2022)
6.5.1 Infectious Disease Vaccine Market, By Geography
6.5.2 Cancer Vaccine Market, By Geography
6.5.3 Allergy Vaccine Market, By Geography
6.5.4 Others Vaccine Market, By Geography, 2012 - 2022
6.5.5 Others Potential Market, By Geography, 2016 - 2022

Table Of Contents

MarketsandMarkets—Worldwide, market research reports primarily sold for numbers, market segmentation and competitive landscape, within the business leaders.

About the Author


Cite this Report

  
MLA:
MarketsandMarkets. "Vaccine Market - By Technology & Types, Trend Analysis By Various Classes - Live / Attenuated, Subunit, Toxoid, Conjugate, DNA, Recombinant Vector, Synthetic, Dentritic Vaccines And By Indications - Infectious Diseases, Cancer, Allergy, Diabetes, Cardiova" Aug 12, 2012. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/MarketsandMarkets/Vaccine-Market-By-Technology-Types-Trend-Analysis-By-Various-Classes-Live-Attenuated-Subunit-Toxoid-Conjugate-DNA-Recombinant-Vector-Synthetic-Dentritic-Vaccines-And-By-Indications-Infectious-Diseases-Cancer-Allergy-Diabetes-Cardiova-2144-237>
  
APA:
MarketsandMarkets. (2012). Vaccine Market - By Technology & Types, Trend Analysis By Various Classes - Live / Attenuated, Subunit, Toxoid, Conjugate, DNA, Recombinant Vector, Synthetic, Dentritic Vaccines And By Indications - Infectious Diseases, Cancer, Allergy, Diabetes, Cardiova Aug 12, 2012. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/MarketsandMarkets/Vaccine-Market-By-Technology-Types-Trend-Analysis-By-Various-Classes-Live-Attenuated-Subunit-Toxoid-Conjugate-DNA-Recombinant-Vector-Synthetic-Dentritic-Vaccines-And-By-Indications-Infectious-Diseases-Cancer-Allergy-Diabetes-Cardiova-2144-237>
  
US$ 4,650.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Market Research from one place.